ArticleJournal of experimental & clinical cancer research : CR2019

The dual PI3K/mTOR inhibitor BEZ235 restricts the growth of lung cancer tumors regardless of EGFR status, as a potent accompanist in combined therapeutic regimens.

Yi-Ying Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.